Bacterial Vaginosis
Bacterial Vaginosis (BV) is an infection of the vagina caused by an excessive growth of bacteria, resulting in symptoms such as increased vaginal discharge with a fish-like odor, burning sensation during urination, and occasionally itching. Though some women may be asymptomatic, BV can double the risk of acquiring sexually transmitted infections and increase the likelihood of early delivery in pregnant women.
Health Outcomes
- Acceptability of Lactobacillus crispatus
- Acceptability of Probiotic (Lactobacillus crispatus CTV-05) During Pregnancy
- Adherence to Vaginal Mucosa
- Adhesion to Cervicovaginal Epithelial Cells
- Altered Antibiotic Susceptibility
- Altered Bacterial Proportions
- Altered Lactobacilli Composition
- Altered Microbial Population Composition
- Altered Microbial Profile
- Altered Pathogenic Bacterial Biomolecules
- Altered Relative Abundance of Specific Bacteria
- Changed Vaginal Microbiota Composition
- Colonization with Lactobacillus Crispatus
- Colonization with Lactobacillus jensenii Post-Treatment
- Decreased Abundance of Lactobacillaceae
- Detected Vaginal Colonization by Probiotic Strain
- Disrupted Bacterial Cell Membranes
- Elevated Viable Bacterial Counts
- Enhanced Adhesion of Beneficial Bacteria
- Enhanced Antibacterial Effect
- Enhanced Antimicrobial Capacity
- Enhanced Antimicrobial Peptide Production
- Enhanced Bacterial Growth
- Enhanced Pathogen Protection
- Enhanced Probiotic Presence
- Enhanced Resistance to Pathogenic Bacteria
- Enhanced Vaginal Epithelial Cell Adhesion
- Enhanced Vaginal Health
- Enhanced Vaginal Immune Defense
- Formation of Bifidobacteria Predominant Microbiota
- Improved Amsel Score for Bacterial Vaginosis
- Improved Antagonistic Activity Against Undesirable Microorganisms
- Improved Antibacterial Activity
- Improved Antimicrobial Ability
- Improved Asymptomatic Bacterial Vaginosis
- Improved Bacterial Survival Rate
- Improved Bacterial Vaginosis Treatment
- Improved Bacterial Viability Under Stress
- Improved Colonization Resistance to Pathogens
- Improved Cure Rate
- Improved Lactobacillus Abundance
- Improved Microbial Identification
- Improved Microbial Safety
- Improved Nugent Score
- Improved Phagocytic Activity
- Improved Probiotic Functionality
- Improved Probiotic Suitability
- Improved Quality of Probiotic Food Products
- Improved Tolerability of Lactobacillus crispatus CTV-05
- Improved Tolerance to Vaginal Suppository
- Improved Vaginal Barrier Integrity
- Improved Vaginal Colonization with Probiotics
- Improved Vaginal Dysbacteriosis
- Improved Vaginal Epithelial Cell Adherence
- Improved Vaginal Flora
- Improved Vaginal Health
- Improved Vaginal Health Assessment Score
- Improved Vaginal Microbial Pattern
- Improved Vaginal Microbiota
- Improved Vaginal Microbiota Balance
- Improved Vaginal pH
- Increased Abundance of Lactobacillus Crispatus
- Increased Abundance of Specific Bacterial Species
- Increased Aerobic to Anaerobic Bacteria Ratio
- Increased Antagonistic Activity Against Undesirable Microorganisms
- Increased Antibacterial Activity
- Increased Antibacterial Activity Against Pathogens
- Increased Antibiotic-Resistant Enterococcal Dissemination
- Increased Antipathogen Activity Against Escherichia coli
- Increased Antipathogen Activity Against Staphylococcus Aureus
- Increased Atopobium Growth
- Increased Autochthonous Bacteria Levels
- Increased Autochthonous Lactic Acid Bacteria Levels
- Increased Bacterial Aggregation
- Increased Bacterial Proliferation
- Increased Bacterial Survival
- Increased Beneficial Bacterial Colonization
- Increased Beneficial Bacterial Counts
- Increased Bifidobacteria Levels
- Increased Cell Hydrophobicity
- Increased Dispersal of Pathogenic Bacteria
- Increased Economic Burden Due to Higher Antibiotic Costs
- Increased Endogenous Bacteria
- Increased Inhibition of Pathogenic Bacteria
- Increased Lactobacilli Abundance
- Increased Lactobacilli Colonization
- Increased Lactobacilli Levels
- Increased Lactobacilli Populations
- Increased Lactobacilli Release
- Increased Lactobacillus Bacterial Load
- Increased Lactobacillus Count
- Increased Lactobacillus Levels
- Increased Lactobacillus Population
- Increased Lactobacillus Species Count
- Increased Microbial Diversity
- Increased Persistence of Probiotic Strains in Vaginal Tract
- Increased Probiotic Bacteria Colonization
- Increased Proportion of Aerobic and Anaerobic Bacteria
- Increased Tetracycline Resistance
- Increased Total Anaerobic Gram-Positive Bacteria Counts
- Increased Total Bacterial Abundance
- Increased Total Bacterial Count
- Increased Total Bacterial Load
- Increased Trichomonas Vaginalis Growth
- Increased Vaginal Colonization
- Increased Vaginal Colonization by Lactobacillus crispatus CTV-05
- Increased Vaginal Lactobacilli
- Increased Vaginal Lactobacilli Colonization
- Increased Vaginal Lactobacilli Levels
- Increased Vaginal Lactobacilli Presence
- Increased Viable Bacteria Count
- Inhibited Adhesion of Mobiluncus
- Inhibition of Harmful Bacterial Growth
- Maintained Antibiotic Susceptibility
- Maintained Bacterial Diversity
- Maintained Normal Vaginal Microbiota
- Maintained Vaginal Eubiosis
- Maintained Vaginal Homeostasis
- Maintained Vaginal Microbiota
- Microbial Community Characterization
- Microbiome Remodeling
- Modulated Vaginal Microbiota Diversity
- Modulation of Microbiota Activity
- No Adverse Effects on Body Weight or Food Intake
- No Change in Nugent Score
- No Reduction in Streptococcus agalactiae
- No Significant Change in Health Variables
- No Significant Changes in Blood Parameters
- No Significant Difference in Primary Outcomes
- No Significant Effect on Toxin-Producing C. difficile Carriage
- No Significant Improvement in Vaginal Nugent Score
- No Significant Increase in Adverse Effects
- Non-Toxic Colonization
- Non-toxicity to Cervicovaginal Epithelial Cells
- Normalized Nugent Score
- Normalized Vaginal Microbiota
- Plasmid-Mediated Niche Adaptation in Lactobacillaceae
- Presence of Vaginal Hydrogen Peroxide-Producing Lactobacilli
- Preventive Effect Against Streptococcus agalactiae Infection
- Protection Against Vaginal Dysbiosis
- Reduced Abundance of Harmful Bacteria
- Reduced Abundance of Pro-Pathogenic Bacteria
- Reduced Adhesion of Enterococcus faecalis
- Reduced Adhesion of Escherichia coli
- Reduced Adhesion of Gardnerella
- Reduced Adhesion of Streptococcus agalactiae
- Reduced Aerobic Vaginitis Risk
- Reduced Amsel Score
- Reduced Asymptomatic Bacterial Vaginosis
- Reduced BV-Associated Bacteria
- Reduced Bacterial Colonization
- Reduced Bacterial Load
- Reduced Bacterial Vaginosis
- Reduced Bacterial Vaginosis Severity
- Reduced Candida albicans Growth
- Reduced Chlamydia trachomatis Infectivity
- Reduced Clostridia Cluster XIV
- Reduced Clostridium Counts
- Reduced Colonization with Probiotic Lactobacilli
- Reduced Colonization with Probiotic Lactobacillus crispatus
- Reduced Concentration of Bacterial Vaginosis-Associated Bacteria
- Reduced Cytotoxicity Induced by Gardnerella Vaginalis
- Reduced Defense Gene Activity for Gram-Negative Pathogens
- Reduced Dysbiosis-Associated Bacteria Growth
- Reduced Enterococci Counts
- Reduced Escherichia coli Counts
- Reduced GBS Colonization
- Reduced Gardnerella Vaginalis Abundance
- Reduced Gardnerella Vaginosis Prevalence
- Reduced Gardnerella spp. Abundance
- Reduced Gram-Negative Bacteria Levels
- Reduced Growth of Harmful Bacteria
- Reduced Harmful Bacteria Species
- Reduced Harmful Bacterial Populations
- Reduced Harmful Microorganisms
- Reduced Incidence of Gynaecological Infections
- Reduced Incidence of Side Infections during Antibiotic Treatments
- Reduced Infection Recurrence
- Reduced Lactobacilli Levels
- Reduced Lactobacillus Counts
- Reduced Localized Infection
- Reduced Malodorous Discharge
- Reduced Microbial Growth
- Reduced Nugent Score
- Reduced Pathogen Adhesion to Vaginal Epithelial Cells
- Reduced Pathogenic Bacteria
- Reduced Pathogenic Bacteria Levels
- Reduced Pathogenic Bacteria Load
- Reduced Pathogenic Bacterial Abundance
- Reduced Pathogenic Bacterial Activity
- Reduced Pathogenic Bacterial Growth
- Reduced Pathogenic Bacterial Invasion
- Reduced Pathogenic Bacterial Populations
- Reduced Potential Pathogenic Bacteria
- Reduced Preterm Delivery
- Reduced Rectovaginal Bacterial Colonization
- Reduced Recurrence of Bacterial Vaginosis
- Reduced Risk of Chorioamnionitis
- Reduced Risk of Genital Infections
- Reduced Risk of Gynaecological Infections
- Reduced Secretion Consistency
- Reduced Staphylococcal Counts
- Reduced Staphylococcus Aureus Virulence
- Reduced Streptococcus agalactiae Growth
- Reduced Total Bacterial Levels
- Reduced Ubiquitous Bacteria Levels
- Reduced Urogenital Infections
- Reduced Urogenital Pathogen Activity
- Reduced Urogenital Pathogen Growth
- Reduced Vaginal Coliform Levels
- Reduced Vaginal Coliforms
- Reduced Vaginal Colonization
- Reduced Vaginal Colonization by Probiotic Lactobacillus
- Reduced Vaginal Colonization of Pathogenic Bacteria
- Reduced Vaginal Dysbiosis-Associated Infection Risk
- Reduced Vaginal Epithelial Cell Damage
- Reduced Vaginal Group B Streptococcus Colonization
- Reduced Vaginal Inflammation
- Reduced Vaginal Pathogen Load
- Reduced Vaginal Pathogens
- Reduced Vaginal Symptom Score
- Reduced Vaginal pH
- Reduced Vaginitis Recurrence
- Regulated Host Epithelial Cells
- Restored Endogenous Microbiota Equilibrium
- Restored Relative Abundance of Specific Bacteria
- Restored Urogenital Tract Microbiome
- Restored Vaginal Flora
- Restored Vaginal Microbiota
- Safe Use of Lactobacillus reuteri NCIMB 30242
- Safety of Lactobacillus crispatus Consumption
- Stable Antibiotic Susceptibility Profiles
- Stable Bacterial Populations
- Stable Enterobacterial Numbers
- Stable Vaginal Microbiota
- Sustained Remission of Bacterial Vaginosis
- Unchanged Gardnerella vaginalis Concentration
- Vaginal Colonization by Lactobacillus Strains
- Vaginitis Cure or Remission Rate